#
Publication:

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy (2012)

Author(s): Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, Plummer R, Boitano M, Calabro L, De Rossi C, Di Giacomo AM, Ferrucci PF, Ridolfi L, Altomonte M, Miracco C, Balestrazzi A, Maio M

      • Date: 11-08-2011
      • Journal: Cancer Immunology, Immunotherapy
      • Volume: 61
      • Issue: 1
      • Pages: 41-48
      • Publisher: Springer
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: Uveal melanoma Ipilimumab Cytotoxic T-lymphocyte antigen-4 Melanoma Immunotherapy T-LYMPHOCYTE ANTIGEN-4 CHOROIDAL MELANOMA PHASE-II ANTI-CTLA-4 ANTIBODY PROGNOSTIC-FACTORS LIVER METASTASES SURVIVAL EXPERIENCE ENUCLEATION MORTALITY

      Staff

      Professor Ruth Plummer
      Clin Prof of Experimental Cancer Med